Evolent Health Inc. (NYSE:EVH) shares were up 4.9% on Wednesday . The company traded as high as $24.91 and last traded at $24.69, with a volume of 84,677 shares trading hands. The stock had previously closed at $23.53.

A number of research analysts have recently weighed in on EVH shares. Zacks Investment Research downgraded Evolent Health from a “hold” rating to a “sell” rating in a research note on Wednesday, May 4th. Canaccord Genuity reissued a “buy” rating on shares of Evolent Health in a research note on Friday, May 13th. FBR & Co reissued a “buy” rating on shares of Evolent Health in a research note on Saturday, May 14th. Leerink Swann reissued a “buy” rating and issued a $20.00 price target on shares of Evolent Health in a research note on Monday, May 16th. Finally, Jefferies Group started coverage on Evolent Health in a research note on Tuesday, July 26th. They issued a “buy” rating and a $28.00 price target on the stock. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. Evolent Health currently has a consensus rating of “Buy” and an average target price of $22.50.

The stock has a market capitalization of $1.51 billion and a price-to-earnings ratio of 6.72. The company’s 50 day moving average price is $20.73 and its 200-day moving average price is $13.85.

Evolent Health (NYSE:EVH) last posted its earnings results on Thursday, August 4th. The company reported ($0.12) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.04. The company had revenue of $56.50 million for the quarter, compared to the consensus estimate of $51.96 million. During the same period in the previous year, the firm posted ($0.95) EPS. The business’s quarterly revenue was up 443.3% compared to the same quarter last year. On average, equities analysts expect that Evolent Health Inc. will post ($0.62) earnings per share for the current year.

A hedge fund recently raised its stake in Evolent Health stock. Schroder Investment Management Group raised its position in Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned about 0.60% of Evolent Health worth $4,310,000 at the end of the most recent reporting period.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.